跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE HCL INJECTION USP 1% (50MG/5ML) - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE HCL INJECTION USP 1% (50MG/5ML)
Authorized
STANDARD
LIDOCAINE HCL INJECTION USP 1% (50MG/5ML)
Valesco Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
89644be44b315f20
Company
Valesco Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
89644be44b315f20
Drug Approval Canada Name
LIDOCAINE HCL INJECTION USP 1% (50MG/5ML)
Product Name
LIDOCAINE HCL INJECTION USP 1% (50MG/5ML)
Status
Cancelled Post Market
Status Date
2018-09-05
Original Market Date
2010-11-17
Din
02348195
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB02 LIDOCAINE
Atc Name
n 01 bb 02
Aig Number
0101280004
Company Name
Valesco Pharmaceuticals Inc
Company Address
3592 Boul. Poirier, Saint-Laurent, Quebec, Canada, H4R 2J5
Company Detail Path
/organization/valesco-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Valesco Pharmaceuticals Inc
Country Name
Canada
Province Name
Quebec
City Name
saint-laurent,quebec,country_ca
Address
3606 boul Poirier
Active Ingredients
LIDOCAINE HYDROCHLORIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
89644be44b315f20
Type
Standard
Back to Health Canada Approvals